![Heidi Hagen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Heidi Hagen
Director/Board Member at
VERICEL CORPORATION
Net worth: 1 M $ as of 31/08/2026
Profile
Heidi M.
Hagen is the founder of Vineti, Inc. Current jobs include Independent Director at Vericel Corp.
since 2013, Director at Obsidian Therapeutics, Inc. starting in 2026, Independent Director at A-Alpha Bio, Inc. since 2023, and Director at Obsidian Therapeutics, Inc. Former jobs include Independent Director at Alaunos Therapeutics, Inc. in 2021, Director at Lykan Biosciences LLC, Senior Vice President-Operations at Dendreon Corp.
from 2002 to 2012, Chief Operating & Commercial Officer at ZappRx, Inc. in 2015, Global Chief Operating Officer at SOTIO LLC from 2013 to 2014, Chief Technical Officer at Sonoma Biotherapeutics, Inc., and Global Chief Operating Officer at SOTIO Biotech as.
Education includes undergraduate degree from the University of Washington in 1990, graduate degree from the University of Washington in 1993, and MBA from the University of Washington in 2001.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VERICEL CORPORATION 0.07% | 29/04/2026 | 35,050 ( 0.07% ) | 1 M $ | 31/08/2026 |
-.--% | 03/08/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Heidi Hagen active positions
| Companies | Position | Start |
|---|---|---|
| VERICEL CORPORATION | Director/Board Member | 23/08/2013 |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Director/Board Member | - |
A-Alpha Bio, Inc.
 A-Alpha Bio, Inc. Packaged SoftwareTechnology Services Develops a synthetic biology platform to aid in the development of drugs | Director/Board Member | 27/06/2023 |
Former positions of Heidi Hagen
| Companies | Position | End |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Chief Executive Officer | 30/08/2021 |
Vineti, Inc.
 Vineti, Inc. Packaged SoftwareTechnology Services Develops a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies | Founder | 01/02/2021 |
ZappRx, Inc.
 ZappRx, Inc. Miscellaneous Commercial ServicesCommercial Services Offers communication related services to pharmaceutical & healthcare providers | Chief Operating Officer | 01/06/2015 |
Sotio LLC
 Sotio LLC BiotechnologyHealth Technology Operates as a biotechnology company that develops active cellular immunotherapy dendritic cells for the treatment of cancer and autoimmune diseases | Chief Operating Officer | 01/04/2014 |
| DENDREON CORPORATION | Chief Operating Officer | 01/05/2012 |
Training of Heidi Hagen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
95
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Vericel Corp.
 Vericel Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures and markets two advanced cell therapy products for sports medicine and severe burn care | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
 Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
ZappRx, Inc.
ZappRx, Inc. Miscellaneous Commercial ServicesCommercial Services Offers communication related services to pharmaceutical & healthcare providers | Commercial Services |
Sotio LLC
Sotio LLC BiotechnologyHealth Technology Operates as a biotechnology company that develops active cellular immunotherapy dendritic cells for the treatment of cancer and autoimmune diseases | Health Technology |
Vineti, Inc.
Vineti, Inc. Packaged SoftwareTechnology Services Develops a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies | Technology Services |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
A-Alpha Bio, Inc.
A-Alpha Bio, Inc. Packaged SoftwareTechnology Services Develops a synthetic biology platform to aid in the development of drugs | Technology Services |
Sonoma Biotherapeutics, Inc.
 Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | Health Technology |
Lykan Biosciences LLC | |
Sotio Biotech AS
 Sotio Biotech AS BiotechnologyHealth Technology Develops potent immunotherapies | Health Technology |
- Stock Market
- Insiders
- Heidi Hagen
